Bristol-Myers Squibb Co (BMY):企業の財務・戦略的SWOT分析

◆英語タイトル:Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1633
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:79
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Bristol-Myers Squibb Co (BMY) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that discovers, develops, licenses, manufactures, markets, distributes and sells medicines to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology and virology (including hepatitis B, hepatitis C and HIV infection) therapeutic projects. The company offers its products across the world to retail pharmacies, wholesalers, hospitals, medical professionals and government entities. BMS provides its products in the US, Europe, Japan and other countries. The company conducts research to focus on the discovery and development of novel medicines that address serious diseases in areas of significant unmet medical need. BMS is headquartered in New York City, New York, the US.

Bristol-Myers Squibb Co Key Recent Developments

Apr 07,2020 Bristol Myers Squibb expands patient support programs to help newly uninsured patients in the U.S
Apr 07,2020 Updated Statement: Bristol Myers Squibb on Coronavirus (COVID-19)
Mar 27,2020 Novartis partners with life sciences companies to fight Covid-19
Mar 21,2020 Updated Statement: Bristol Myers Squibb on Coronavirus (COVID-19)

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Bristol-Myers Squibb Co – Key Facts
Bristol-Myers Squibb Co – Key Employees
Bristol-Myers Squibb Co – Key Employee Biographies
Bristol-Myers Squibb Co – Major Products and Services
Bristol-Myers Squibb Co – History
Bristol-Myers Squibb Co – Company Statement
Bristol-Myers Squibb Co – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Bristol-Myers Squibb Co – Business Description
Business Segment: BioPharmaceuticals
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Others
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: United States
Performance
R&D Overview
Bristol-Myers Squibb Co – Corporate Strategy
Bristol-Myers Squibb Co – SWOT Analysis
SWOT Analysis – Overview
Bristol-Myers Squibb Co – Strengths
Bristol-Myers Squibb Co – Weaknesses
Bristol-Myers Squibb Co – Opportunities
Bristol-Myers Squibb Co – Threats
Bristol-Myers Squibb Co – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Bristol-Myers Squibb Co, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 07, 2020: Bristol Myers Squibb expands patient support programs to help newly uninsured patients in the U.S
Apr 07, 2020: Updated Statement: Bristol Myers Squibb on Coronavirus (COVID-19)
Mar 27, 2020: Novartis partners with life sciences companies to fight Covid-19
Mar 21, 2020: Updated Statement: Bristol Myers Squibb on Coronavirus (COVID-19)
Mar 18, 2020: Bristol Myers Squibb appoints Elizabeth Mily as executive vice president, strategy & business development
Mar 05, 2020: Bristol Myers Squibb unveils new branding
Feb 28, 2020: FinnGen grows to one of the largest private-public studies in the world
Feb 06, 2020: Bristol-Myers Squibb reports fourth quarter and full year financial results for 2019
Feb 04, 2020: BMS and BioMotiv launch Anteros Pharmaceuticals
Feb 04, 2020: BioMotiv and Bristol-Myers Squibb announce the launch of Anteros Pharmaceuticals
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Bristol-Myers Squibb Co, Key Facts
Bristol-Myers Squibb Co, Key Employees
Bristol-Myers Squibb Co, Key Employee Biographies
Bristol-Myers Squibb Co, Major Products and Services
Bristol-Myers Squibb Co, History
Bristol-Myers Squibb Co, Subsidiaries
Bristol-Myers Squibb Co, Joint Venture
Bristol-Myers Squibb Co, Key Competitors
Bristol-Myers Squibb Co, Ratios based on current share price
Bristol-Myers Squibb Co, Annual Ratios
Bristol-Myers Squibb Co, Annual Ratios (Cont...1)
Bristol-Myers Squibb Co, Annual Ratios (Cont...2)
Bristol-Myers Squibb Co, Interim Ratios
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Bristol-Myers Squibb Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Bristol-Myers Squibb Co, Performance Chart (2015 - 2019)
Bristol-Myers Squibb Co, Ratio Charts
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Bristol-Myers Squibb Co (BMY):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitsubishi Heavy Industries, Ltd.:企業の戦略・SWOT・財務分析
    Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Sonoco Products Co (SON):企業の財務・戦略的SWOT分析
    Sonoco Products Co (SON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kemin Industries Inc:企業の戦略・SWOT・財務情報
    Kemin Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Kemin Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Royal DSM NV (DSM)-製薬・医療分野:企業M&A・提携分析
    Summary Royal DSM NV (DSM) is a life sciences and materials sciences company, which focuses on health, nutrition and materials sectors. The company offers a wide range of products such as anti-invectives, polyesters, vitamins and other ingredients, performance materials to diverse end markets. It pr …
  • Celgene Corporation:企業の戦略・SWOT・財務情報
    Celgene Corporation - Strategy, SWOT and Corporate Finance Report Summary Celgene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Synaffix BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Synaffix BV (Synaffix) is a biotechnology company that discovers and develops site-specific antibody-drug conjugates technology platforms. The company develops its products through its proprietary technology and GlycoConnect. It constructs homogenous and stable ADCs with the aid of a payload …
  • Nippon Sheet Glass Company Limited :企業の戦略・SWOT・財務情報
    Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report Summary Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • OBI Pharma Inc (4174):医療機器:M&Aディール及び事業提携情報
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • Tata Chemicals Ltd (TATACHEM):企業の財務・戦略的SWOT分析
    Summary Tata Chemicals Ltd (TCL) is a chemical company engaged in offering industry, living, and farm essential chemicals. The company's products include dals, consumer salt, water purifier, soda ash, spices, sodium bicarbonate, allied chemicals, industrial salt, customized fertilizers, cement, fert …
  • Select Energy Services Inc (WTTR):企業の財務・戦略的SWOT分析
    Select Energy Services Inc (WTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Oasmia Pharmaceutical AB (OASM):製薬・医療:M&Aディール及び事業提携情報
    Summary Oasmia Pharmaceutical AB (Oasmia Pharmaceutical) is a pharmaceutical company that develops drugs for human and veterinary oncology. The company’s product portfolio consists of animal health products that include doxophos vet and paccal vet and human health products which include doxophos, pa …
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Avraham Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Avraham Pharmaceuticals Ltd (Avraham Pharmaceuticals) is a pharmaceutical company that develops novel products for treatment and prevention of neurodegenerative disorders. The company offers a product, Ladostigil. It offers product in the therapeutic area of mild cognitive impairment. Avraha …
  • Sphere Fluidics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sphere Fluidics Ltd (Sphere Fluidics) is a life sciences company that offers analytical instrumentation and collaborative research services. The company offers products such as research instruments, consumables and industrial systems. Its research instruments include picodroplet single cell …
  • Bank Gutmann AG:企業の戦略・SWOT・財務情報
    Bank Gutmann AG - Strategy, SWOT and Corporate Finance Report Summary Bank Gutmann AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • United Internet AG:企業のM&A・事業提携・投資動向
    United Internet AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Internet AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Tulmar Safety Systems Inc.:企業の戦略・SWOT・財務情報
    Tulmar Safety Systems Inc. - Strategy, SWOT and Corporate Finance Report Summary Tulmar Safety Systems Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • First Gen Corp (FGEN):企業の財務・戦略的SWOT分析
    First Gen Corp (FGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • AECI Ltd (AFE):企業の財務・戦略的SWOT分析
    AECI Ltd (AFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Hunan Fangsheng Pharmaceutical Co Ltd (603998):製薬・医療:M&Aディール及び事業提携情報
    Summary Hunan Fangsheng Pharmaceutical Co Ltd (Fangsheng Pharma) is a research-based comprehensive pharmaceutical enterprise offers research, development, manufacturing and sales of pharmaceuticals. The enterprise’ products include tablets, capsules, granules, oral suspension, powder, suppository, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆